Latest Continuous Disclosure News

Alpha HPA has responded to ASX inquiries confirming the material market sensitivity of its signed Letter of Intent (LOI) and related surge in semiconductor sector sales, underscoring the strategic importance of its high purity materials.

Arovella Therapeutics has requested a voluntary suspension of its ASX-listed securities pending a material announcement on a capital raising, expected by 17 February 2025.

Cleo Diagnostics has responded to an ASX price query following a notable rise in its share price and trading volume, underscoring its patented ovarian cancer detection technology and ongoing U.S. clinical trials.

E79 Gold Mines responds to ASX inquiries about recent price and volume spikes, linking market activity to a neighbour's gold find near its Laverton South Project.

Cannindah Resources Limited has responded to an ASX price query, confirming no undisclosed information explains recent stock price movements and affirming compliance with continuous disclosure rules.

RLF AgTech Ltd has successfully raised approximately $2.42 million through an Entitlement Issue and Shortfall Placement, reflecting strong shareholder confidence in its turnaround strategy and growth prospects in Australia and Asia.

Pact Group Holdings has responded to an ASX price query, confirming no undisclosed material information and previewing a modest earnings uplift for the half-year ending December 2024.

Green Critical Minerals Limited has launched an offer of up to 10,000 Listed Options at no cost to remove trading restrictions on previously issued options, aiming to facilitate secondary trading and enhance liquidity for investors.

Dateline Resources Limited’s shares were suspended from ASX trading on 3 February 2025 due to a delayed periodic report, raising questions about compliance and future market activity.

Magnis Energy Technologies reports ongoing progress on its Nachu Graphite Project while grappling with Imperium3’s bankruptcy and a prolonged ASX trading suspension.

Echo IQ confirms the material significance of its pre-submission FDA meeting for EchoSolv HF, marking a pivotal step toward US market entry and commercialisation.

Newfield Resources clarifies its $10 million loan facility status, postpones key sampling work, and updates on ongoing dispute with Octea Limited, signaling cautious navigation through financial and operational challenges.